NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
13/03/2026
Voltar para busca
Dado oficial do USPTO
DEGRADABALL
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
44
Atualização mais recente
14/03/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
1, 5
Data de depósito
19/07/2018
Data de registro
12/11/2019
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
13/03/2026
Última transação
14/03/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
706
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
03
Localização do titular
KR
Examinador
CHARLON, BARNEY
Localização atual
Historical data usage
Titulares e representantes
Titulares
Lemonex Inc.
Lemonex Inc.
Representantes
Jong H Park The PL Law Group, PLLC
Classificação técnica
Classes Nice
Classe 1Classe 5
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Chemical stabilizers for use in the manufacture of cosmetics; soil adjuvant for agricultural use; chemicals for use in agriculturehorticulture and forestryexcept fungicidesherbicidesinsecticides and parasiticides; antibody reagents for scientific purposes; active chemical ingredients for use in the manufacture of anti-cancer drugs; active chemical ingredients for use in the manufacture of insecticides; antioxidants for use in the manufacture of cosmetics; antioxidants for use in the manufacture of food and beverages; cell growth media for growing cells for use in scientific research; biochemicals for in vitro and in vivo scientific use; biotechnology reagents for scientific and research use; chemical additives for use in the manufacture of pharmaceuticals; reagents for cell straining for scientific and research use; reagents for cell transformation for scientific and research use; reagents for medical research; reagents for research purposes; silica powder; silicagel powder; silicasol in the nature of a colloid made out of silica particles for use int the manufacture of cosmetics and pharmaceuticals
Classe 5
Pharmaceutical and veterinary preparationsa drug delivery system comprising a porous silica particle for the continuous release of a wide variety of therapeutic agents and physiologically active substances; preparations for killing weeds and destroying vermin; Drug delivery agents in the form of porous silica particles that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; radiological contrast substances for medical purposes; radioisotope markers for therapeutic or diagnostic use; radio-isotope markers for therapeutic or diagnostic use; diagnostic reagents and contrast media for medical purposes; skin care preparations for medical purposes; drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; reagents for medical use; veterinary preparations for treatment of intestinal bacteria; drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; drug delivery agents in the form of coatings for tablets that facilitate the delivery of pharmaceutical preparations; drug delivery agents in the form of dissolvable films that facilitate the delivery of pharmaceutical preparations; drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals
Publicações
Histórico de despachos e eventos da marca no USPTO.
44 publicações encontradas
71AG
REGISTERED-SEC.71 ACCEPTED
13/03/2026
PRAN
POST REGISTRATION ACTION MAILED NO RESPONSE REQUIRED
13/03/2026
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
09/03/2026
ES71
TEAS SECTION 71 RECEIVED
11/11/2025
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
12/11/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
21/05/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
21/05/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
21/05/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
21/05/2020
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
21/05/2020
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
27/03/2020
FICS
FINAL DISPOSITION NOTICE SENT TO IB
05/03/2020
FIMP
FINAL DISPOSITION PROCESSED
05/03/2020
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
12/02/2020
CORV
REVIEW OF CORRESPONDENCE COMPLETE - CERTIFICATE OF REG MAILED
10/12/2019
R.PR
REGISTERED-PRINCIPAL REGISTER
12/11/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
27/08/2019
PUBO
PUBLISHED FOR OPPOSITION
27/08/2019
GPNX
NOTIFICATION PROCESSED BY IB
23/08/2019
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
07/08/2019
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
07/08/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07/08/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
18/07/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
27/06/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
27/06/2019
ALIE
ASSIGNED TO LIE
25/06/2019
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
20/06/2019
NREP
NEW REPRESENTATIVE AT IB RECEIVED
02/05/2019
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
22/04/2019
GNFR
FINAL REFUSAL E-MAILED
22/04/2019
CNFR
FINAL REFUSAL WRITTEN
22/04/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
30/03/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
29/03/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
29/03/2019
RFNT
REFUSAL PROCESSED BY IB
02/02/2019
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
14/01/2019
RFRR
REFUSAL PROCESSED BY MPU
14/01/2019
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
03/01/2019
CNRT
NON-FINAL ACTION WRITTEN
02/01/2019
MAFR
APPLICATION FILING RECEIPT MAILED
01/01/2019
DOCK
ASSIGNED TO EXAMINER
26/12/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
26/12/2018
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
20/12/2018
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace DEGRADABALL ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.